<unk>  <unk>   - is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable"), or worsen ("progression") during treatments. The<unk>  were published in February, 2000 by an international collaboration including the European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) of the United States, and the National Cancer Institute of Canada Clinical Trials Group. Today, the majority of clinical trials<unk> g cancer treatments for objective<unk>  in<unk><unk>  are using<unk> .
Response Evaluation Criteria in Solid Tumors
International Classification of Diseases for Oncology
Cancer staging
Tumor marker
Eastern Cooperative Oncology Group
Lymphadenopathy classification
Adjuvant therapy
Cluster of differentiation